Form4insider filings, from the source

SEC Form 3 · accession 0001123292-15-000961

FIVE PRIME THERAPEUTICS INC · FPRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Brian Russell Wong
Officer — SVP, Research
Period of report
Jun 12, 2015
Accepted (ET)
Jun 24, 2015 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———22,738D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F2$4.56holding————Feb 12, 2019Common Stock338—D
Employee Stock Option (right to buy)F2$6.89holding————Jul 28, 2020Common Stock11,788—D
Employee Stock Option (right to buy)F3$8.49holding————Jul 13, 2021Common Stock9,756—D
Employee Stock Option (right to buy)F4$5.54holding————Jul 15, 2022Common Stock32,520—D
Employee Stock Option (right to buy)F5$7.26holding————Jul 18, 2023Common Stock20,324—D
Employee Stock Option (right to buy)F6$11.14holding————Aug 21, 2024Common Stock20,000—D

Explanation of responses